These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 7826875)
21. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia. Fawaz NA; Tamim H; Almawi WY Am J Infect Control; 2005 Apr; 33(3):189-91. PubMed ID: 15798675 [TBL] [Abstract][Full Text] [Related]
22. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns. Mangano AM; Remesar M; del Pozo A; Sen L J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282 [TBL] [Abstract][Full Text] [Related]
23. Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I. Yao K; Hisada M; Maloney E; Yamano Y; Hanchard B; Wilks R; Rios M; Jacobson S J Infect Dis; 2006 Feb; 193(3):427-37. PubMed ID: 16388491 [TBL] [Abstract][Full Text] [Related]
24. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires]. Blejer JL; Saguier MC; Salamone HJ; Carreras LA Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226 [TBL] [Abstract][Full Text] [Related]
25. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors. Kwon SY; Lim AH; Park JY; Han SH; Cho NS J Med Virol; 2008 Oct; 80(10):1864-7. PubMed ID: 18712809 [TBL] [Abstract][Full Text] [Related]
26. [Multicenter study of HTLV-I and HTLV-II infection in Spain. Spanish Group for the Study of HTLV-II/II Infection]. Soriano V; Calderón E; Cilla G; Aguilera A; Merino F; Gutiérrez M Med Clin (Barc); 1993 Apr; 100(13):492-6. PubMed ID: 8479231 [TBL] [Abstract][Full Text] [Related]
27. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia. Ul-Hassan Z; Al-Bahrani AT; Panhotra BR Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814 [TBL] [Abstract][Full Text] [Related]
28. Human T-cell lymphotropic virus types I and II infections in patients with leukaemia/lymphoma and in subjects with sexually transmitted diseases in Nigeria. Olaleye OD; Ekweozor CC; Li ZL; Opala IE; Sheng Z; Onyemenem TN; Rasheed S Arch Virol; 1996; 141(2):345-55. PubMed ID: 8634025 [TBL] [Abstract][Full Text] [Related]
29. Nondetection of HTLV-I/II and HIV-2 in Thailand, 1991-1992. Lohsomboon P; Young NL; Weniger BG; Atikij B; Limpakarnjanarat K; Khabbaz RF; Kaplan JE J Acquir Immune Defic Syndr (1988); 1994 Sep; 7(9):992-4. PubMed ID: 8051625 [No Abstract] [Full Text] [Related]
30. Is seroprevalence of HTLV-I/II among blood donors in India relevant? Kumar H; Gupta PK Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844 [TBL] [Abstract][Full Text] [Related]
31. Type-specific immune response to human T cell lymphotropic virus (HTLV) type I and type II infections in Nigeria. Olaleye DO; Bernstein L; Sheng Z; Ekweozor CC; Li XY; Sullivan-Halley J; Rasheed S Am J Trop Med Hyg; 1994 Apr; 50(4):479-86. PubMed ID: 8166356 [TBL] [Abstract][Full Text] [Related]
32. Serological patterns and temporal trends of HTLV-1/2 infection in high-risk populations attending Public Health Units in São Paulo, Brazil. Jacob F; Santos-Fortuna E; Azevedo RS; Caterino-de-Araujo A J Clin Virol; 2008 Jun; 42(2):149-55. PubMed ID: 18346935 [TBL] [Abstract][Full Text] [Related]
33. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates. de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T; J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565 [TBL] [Abstract][Full Text] [Related]
34. Prevalence of antibody to human T-cell lymphotropic virus type I/II in people of Caribbean origin in Toronto. Chiavetta J; Nusbacher J; Tam F; Wall A; Steaffens J; Lee H CMAJ; 1992 Nov; 147(10):1493-8. PubMed ID: 1423089 [TBL] [Abstract][Full Text] [Related]
35. Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans. Wiktor SZ; Cannon RO; Atkinson WL; Lutz B; Hook EW; Blattner WA; Quinn TC J Infect Dis; 1992 May; 165(5):920-4. PubMed ID: 1569344 [TBL] [Abstract][Full Text] [Related]
36. Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States. Murphy EL; Watanabe K; Nass CC; Ownby H; Williams A; Nemo G J Infect Dis; 1999 Dec; 180(6):1777-83. PubMed ID: 10558931 [TBL] [Abstract][Full Text] [Related]
37. Human T lymphotropic virus type I/II infection: prevalence and risk factors in individuals testing for HIV in counseling centers from Southern Brazil. Barcellos NT; Fuchs SC; Mondini LG; Murphy EL Sex Transm Dis; 2006 May; 33(5):302-6. PubMed ID: 16505751 [TBL] [Abstract][Full Text] [Related]
38. [Prevalence of HTLV-I and HTLV-II infection in Puglia]. Quarto M; Chironna M; Germinario C; Lopalco PL; Barbuti S Ann Ig; 1996; 8(6):649-55. PubMed ID: 9312232 [No Abstract] [Full Text] [Related]
39. The emerging role of HTLV-I/II and HIV-1 among intravenous drug users in Detroit. Ognjan AF; Lewandowski CA; Belian BT; Burczak J; Markowitz N; Lee H; Saravolatz LD Henry Ford Hosp Med J; 1992; 40(1-2):131-5. PubMed ID: 1428966 [TBL] [Abstract][Full Text] [Related]
40. Prevalence of human T-cell leukemia virus types I and II in Switzerland. Böni J; Bisset LR; Burckhardt JJ; Joller-Jemelka HI; Bürgisser P; Perrin L; Gorgievski M; Erb P; Fierz W; Piffaretti JC; Schüpbach J; J Med Virol; 2004 Feb; 72(2):328-37. PubMed ID: 14695678 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]